 |
| Today's top 5 stories on CNBC |
 |
1. General Mills' New CEO: There's been a change in command at General Mills this week, and the shakeup couldn't have come at a more interesting time. Kendall Powell, the new CEO of General Mills, sits down for an interview with CNBC's Maria Bartiromo.   |
| 2. Profit Bumper: Discussing the booming corn demand, with Hugh Grant, Monsanto chairman/CEO and CNBC's Bill Griffeth. |
| 3. Farewell Third Quarter: Next week marks this year's fourth quarter, with Robert Doll, BlackRock vice Chairman and Global CIO Of Equities. |
| 4. Tech's Toughness: Jabil posts earnings after the close today, with Timothy Main, Jabil Circuit CEO and CNBC's Joe Kernen. |
| 5. NYSE Market Wrap: Melissa Lee reports on the trading day from the NYSE. |
| Click here to view all of today's Top stories |
| Clip of the week: |
 |
 | |
| Cramer on Homes | |
| Mad Money host Jim Cramer says don't buy now. |
 |  |
| SPORTZBIZ w/Darren Rovell: Roger Clemens Not Worth It?(My Second Take) CNBC Sports Business Reporter Darren Rovell blogs on Roger Clemens and his performance with the Yankees this season. Is Clemens really worth the $18.5 Million contract he signed? Darren has the answer. Click here to view posting. |
| Tune in to CNBC Monday to watch the market unfold |
|
| 1. The Four Market Risks: With concerns that the equities market is being naive, what are the risks are the four major worries that threaten the bull run? Melissa Lee reports. |
| 2. Regulating Loans: Barney Frank is drafting a bill that would forces mortgage servicers to bear some liability for failing loans and ban particular broker incentives. What does it mean for investors? Mary Thompson looks at the potential legislation. |
| 3. Washington Week-Ahead: John looks at the buzz on the Hill and the upcoming Washington agenda. Two major talking points will be the beginning ot the new fiscal year as well as the end of quarterly presidential fund-raising. |
| 4. Court Back in Session: Hampton Pearson previews what's on the docket for the Supreme Court this coming term, with a focus on three major cases: the biggest securities litigation case in more than a decade, a patent case with huge implications for computer manufacturers and a case to decide whether federal drug regulation pre-empts prescription drug makers from lawsuits brought by individuals in state courts. |
 |
| CNBC Investing Tools | |
| |
 |  |
 |  |
 |  |
 |
To unsubscribe to this email click here
If this e-mail was forwarded to you and you would like to subscribe to CNBC's Daily Market Wrap, please click here
No comments:
Post a Comment